Medpace debt and dilution—

Borrowings, liquidity, share count and stock-based dilution.

Total debt

USD millions

—

Cash & equivalents

USD millions

$502.688M

Net debt

USD millions

—

Debt / equity

—

Debt / assets

—

Net debt / EBITDA

× · TTM

—

Debt / FCF

× · TTM

—

Interest coverage

× · TTM

—

The reported inputs required for this metric are unavailable in the extracted statements for this period.

Current ratio

0.73×

Diluted shares

Million shares

28.55M shares

Basic shares

Million shares

28.17M shares

Share count growth

-1.49%

Share repurchases

USD millions

$294.764M

Quarterly data

Medpace capital history. Each metric has its own unit. A dash means inputs are missing or the calculation is undefined.
Fiscal period	Ended	Total debtUSD millions	Cash & equivalentsUSD millions	Net debtUSD millions	Debt / equity×	Debt / assets%	Net debt / EBITDA×	Debt / FCF×	Interest coverage×	Current ratio×	Diluted sharesMillion shares	Basic sharesMillion shares	Share count growth%	Share repurchasesUSD millions
FY 2026 Q2	Jun 30, 2026	—	502.69	—	—	—	—	—	—	0.73×	28.55	28.17	-1.49%	294.76
FY 2026 Q1	Mar 31, 2026	—	652.68	—	—	—	—	—	—	0.85×	28.96	28.45	-6.39%	0
FY 2025 Q4	Dec 31, 2025	—	497.05	—	—	—	—	—	—	0.74×	28.98	28.29	-8.59%	0
FY 2025 Q3	Sep 30, 2025	—	285.35	—	—	—	—	—	—	0.57×	28.82	28.14	-9.38%	4.57
FY 2025 Q2	Jun 30, 2025	—	46.33	—	—	—	—	—	—	0.43×	29.14	28.6	-7.71%	540.92
FY 2025 Q1	Mar 31, 2025	—	441.44	—	—	—	—	—	—	0.73×	31.2	30.39	-1.48%	371.9
FY 2024 Q4	Dec 31, 2024	—	669.44	—	—	—	—	—	—	0.93×	31.88	30.95	0.75%	169.87
FY 2024 Q3	Sep 30, 2024	—	656.9	—	—	—	—	—	—	0.99×	32.09	31.05	1.36%	0
FY 2024 Q2	Jun 30, 2024	—	510.89	—	—	—	—	—	—	0.88×	32.09	30.99	1.48%	0
FY 2024 Q1	Mar 31, 2024	—	407.01	—	—	—	—	—	—	0.78×	32	30.84	-0.53%	0
FY 2023 Q4	Dec 31, 2023	—	245.45	—	—	—	—	—	—	0.64×	31.85	30.72	-1.52%	0
FY 2023 Q3	Sep 30, 2023	—	95.21	—	—	—	—	—	—	0.53×	31.76	30.63	-1.23%	0
FY 2023 Q2	Jun 30, 2023	—	39.14	—	—	—	—	—	—	0.44×	31.58	30.54	-6.02%	23.87
FY 2023 Q1	Mar 31, 2023	—	46.92	—	—	—	—	—	—	0.42×	32.16	31.01	-11.2%	120.15
FY 2022 Q4	Dec 31, 2022	—	28.27	—	—	—	—	—	—	0.42×	32.4	31.19	-13.31%	47.18
FY 2022 Q3	Sep 30, 2022	—	31.01	—	—	—	—	—	—	0.41×	32.25	31.01	-13.42%	0
FY 2022 Q2	Jun 30, 2022	—	42.55	—	—	—	—	—	—	0.37×	33.7	32.49	-9.48%	374.72
FY 2022 Q1	Mar 31, 2022	—	82.84	—	—	—	—	—	—	0.61×	36.36	34.92	-2.34%	425.95
FY 2021 Q4	Dec 31, 2021	—	461.3	—	—	—	—	—	—	1.24×	37.86	35.98	1.13%	0
FY 2021 Q3	Sep 30, 2021	—	398.39	—	—	—	—	—	—	1.24×	37.52	35.82	0.74%	6.22
FY 2021 Q2	Jun 30, 2021	—	339.01	—	—	—	—	—	—	1.16×	37.71	35.89	1.44%	55.88
FY 2021 Q1	Mar 31, 2021	—	332.88	—	—	—	—	—	—	1.19×	37.75	35.75	-0.75%	0
FY 2020 Q4	Dec 31, 2020	—	277.77	—	—	—	—	—	—	1.08×	37.69	35.58	-1.27%	47.45
FY 2020 Q3	Sep 30, 2020	—	219.23	—	—	—	—	—	—	1.1×	37.76	35.55	-1.08%	0
FY 2020 Q2	Jun 30, 2020	—	160.9	—	—	—	—	—	—	0.94×	37.33	35.39	-1.26%	9.05
FY 2020 Q1	Mar 31, 2020	—	134	—	—	—	—	—	—	0.89×	38.03	36.02	0.91%	41.78
FY 2019 Q4	Dec 31, 2019	—	131.92	—	—	—	—	—	—	0.92×	37.78	36.04	1.19%	0
FY 2019 Q3	Sep 30, 2019	—	79.29	—	—	—	—	—	—	0.8×	37.84	35.94	1.04%	0
FY 2019 Q2	Jun 30, 2019	—	20.1	—	—	—	—	—	—	0.66×	37.39	35.84	0.9%	0
FY 2019 Q1	Mar 31, 2019	—	30.13	—	—	—	—	—	—	0.69×	37.29	35.7	0.6%	0
FY 2018 Q4	Dec 31, 2018	79.72	23.28	56.45	0.14×	8.24%	0.4×	0.57×	—	0.69×	37.26	35.61	-3.33%	0
FY 2018 Q3	Sep 30, 2018	113.69	22.24	91.45	0.2×	11.97%	0.72×	0.88×	—	0.66×	37.13	35.57	-7.8%	0
FY 2018 Q2	Jun 30, 2018	163.52	22.23	141.29	0.3×	16.89%	1.19×	1.4×	—	0.68×	36.66	35.52	-11.61%	—
FY 2018 Q1	Mar 31, 2018	197.57	22.25	175.32	0.39×	20.3%	1.54×	1.8×	—	0.66×	36.45	35.49	-12.74%	—
FY 2017 Q4	Dec 31, 2017	221.61	26.49	195.13	0.44×	23.31%	1.75×	2.59×	—	0.67×	37.77	36.84	-8.62%	60.32
FY 2017 Q3	Sep 30, 2017	184.62	24.17	160.45	0.34×	19.46%	1.43×	2.19×	—	0.68×	39.33	38.58	3.94%	68.86
FY 2017 Q2	Jun 30, 2017	157.63	29.06	128.57	0.26×	16.36%	1.17×	1.81×	—	0.79×	40.83	40.18	—	26.4
FY 2017 Q1	Mar 31, 2017	160.64	29.32	131.32	0.26×	16.63%	—	—	—	0.86×	41.51	40.67	—	—
FY 2016 Q4	Dec 31, 2016	163.64	37.1	126.54	0.27×	16.71%	1.14×	2.09×	—	0.79×	42.18	40.31	—	0
FY 2016 Q3	Sep 30, 2016	154.62	14.64	139.98	0.25×	15.83%	—	—	—	0.77×	37.62	37.12	—	0

Sources and calculations

Financial inputs from company filings. Last checked Oct 18, 2026. A dash means missing inputs or an undefined calculation.

Period changes use the preceding fiscal quarter or year. Percentage changes divide by the absolute prior value; a zero or missing baseline has no percentage change. Percentage metrics show changes in percentage points.

The SBC option subtracts reported share-based compensation from FCF as an economic-cost scenario. Missing SBC never becomes zero.

Debt uses reported borrowings, with overlapping concepts treated as alternatives. Cash excludes restricted cash and short-term investments. Dilution compares split-normalized weighted average basic shares year over year. Share buyback spending does not by itself measure shares retired.

Market prices: Yahoo Finance · MEDP, USD. Latest completed close Sep 25, 2026. Price data retrieved Sep 28, 2026.

Total debt: Reported borrowing balances. Uses an aggregate including current maturities, or current plus noncurrent debt. Adds separately disclosed short-term borrowings, with commercial paper as a fallback, unless the selected current/aggregate concept already includes them. Finance leases are included when part of the reported debt concept; undisclosed components are not estimated.
Cash & equivalents: Unrestricted reported cash and cash equivalents. Excludes short-term investments and restricted cash.
Net debt: Total debt − cash and equivalents. Negative means net cash.
Debt / equity: Total debt / equity including noncontrolling interests. Nonpositive equity yields unavailable.
Debt / assets: Total debt / total assets × 100.
Net debt / EBITDA: Period-end net debt / (TTM operating income + TTM depreciation and amortization). Negative net debt is retained.
Debt / FCF: Period-end reported debt / positive TTM free cash flow. Reflects the selected reported capex scope and SBC option.
Interest coverage: TTM operating income / positive TTM interest expense. IFRS finance costs can include more than interest.
Current ratio: Current assets / positive current liabilities.
Diluted shares: Reported weighted average diluted shares, normalized for subsequent recorded stock splits. Fourth-quarter counts use a day-weighted annual/nine-month reconstruction where possible.
Basic shares: Reported weighted average basic shares, normalized for subsequent recorded stock splits.
Share count growth: Year-over-year change in split-normalized weighted average basic shares × 100. A dilution proxy; negative means a lower share count.
Share repurchases: Reported cash payments for repurchase of common shares. This is spending, not a buyback yield.